James S Norris

Medical University Of South Carolina

$2,883,665

Attributed

$2,883,665

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $226.6K · FY2005–12

$250K$187.5K$125K$62.5K$0

'05

'06

'07

'08

'09

'10

'11

'12

Funding mix

By agency

NIH$2,883,665 · 5

By mechanism

R01$1,076,116 · 2

P01$1,022,089 · 1

R24$777,989 · 1

P41$7,471 · 1

Top collaborators

No co-investigators on record.

Most similar at Medical University Of South Carolina

Same institution · by research overlap

Besim Ogretmen$19,638,711
Christina Voelkel-Johnson$2,967,908
Lina M Obeid$14,979,081
John Y Dong$5,010,666
Cynthia F. Wright$11,018,594

Others in their field

Top investigators on “Doxorubicin”

Charles A Coltman · Southwest Oncology Group$64,630,528
Norman Wolmark · Nsabp Foundation, Inc.$52,338,276
Gregory H Reaman · National Childhood Cancer Foundation$18,332,016
Laurence H Baker · University Of Michigan At Ann Arbor$12,790,926
Katherine W Ferrara · Stanford University$10,822,980
Kit S Lam · University Of California At Davis$10,711,611

Research focus

DoxorubicinCollagenDeacylationDown-RegulationCessation Of LifeClinically SignificantChemotherapyClinically RelevantAngiogenesisClinicAdhesionsCancer BiologyCancer CellCancer Cell GrowthApoptosisCeramidesCell CycleCell Cycle RegulationCell Fate ControlCell GrowthCisplatinCell LineCellsDrug Resistance